Rockwell Medical (RMTI) EBT Margin Growth (1y) (2011 - 2026)

Rockwell Medical (RMTI) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 342.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -166.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5,404.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1,258.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 8,812.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2,773.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 132.00
10 Rockwell Medical 25.77 Mn 1.88 Mn 2.90 Mn -3,184.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,184.00
Dec 31, 2025 -143.00
Sep 30, 2025 -1,842.00
Jun 30, 2025 -1,653.00
Mar 31, 2025 -210.00
Dec 31, 2024 534.00
Sep 30, 2024 1,437.00
Jun 30, 2024 1,912.00
Mar 31, 2024 143.00
Dec 31, 2023 373.00
Sep 30, 2023 1,341.00
Jun 30, 2023 785.00
Mar 31, 2023 3,536.00
Dec 31, 2022 4,905.00
Sep 30, 2022 2,500.00
Jun 30, 2022 2,890.00
Mar 31, 2022 566.00
Dec 31, 2021 -415.00
Sep 30, 2021 71.00
Jun 30, 2021 -1,738.00